Darren Jeremy Bryk, MD | |
4515 Wiles Rd Ste 201, Coconut Creek, FL 33073-3414 | |
(954) 943-1133 | |
(954) 783-6845 |
Full Name | Darren Jeremy Bryk |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 8 Years |
Location | 4515 Wiles Rd Ste 201, Coconut Creek, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568818409 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 0101275089 (Virginia) | Secondary |
208800000X | Urology | ME158857 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Delray Medical Center | Delray beach, FL | Hospital |
Holy Cross Hospital | Fort lauderdale, FL | Hospital |
Broward Health North | Pompano beach, FL | Hospital |
Westside Regional Medical Center | Plantation, FL | Hospital |
Boca Raton Regional Hospital | Boca raton, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Urology Medical Specialists, Pa | 2466604616 | 11 |
News Archive
In late December 2015, the U.S. Food and Drug Administration proposed a number of new restrictions related to the use of tanning beds, including banning their use among individuals younger than 18 years.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."
Results from a study published in BJU International indicate that penile rehabilitation programs can help restore erectile function following nerve-sparing robot-assisted radical prostatectomy.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Jameson Rybak tried to quit using opioids nearly a dozen times within five years. Each time, he'd wait out the vomiting, sweating and chills from withdrawal in his bedroom.
› Verified 3 days ago
Entity Name | Urology Medical Specialists, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164772935 PECOS PAC ID: 2466604616 Enrollment ID: O20121214000246 |
News Archive
In late December 2015, the U.S. Food and Drug Administration proposed a number of new restrictions related to the use of tanning beds, including banning their use among individuals younger than 18 years.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."
Results from a study published in BJU International indicate that penile rehabilitation programs can help restore erectile function following nerve-sparing robot-assisted radical prostatectomy.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Jameson Rybak tried to quit using opioids nearly a dozen times within five years. Each time, he'd wait out the vomiting, sweating and chills from withdrawal in his bedroom.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Darren Jeremy Bryk, MD 5258 Linton Blvd Ste 203, Delray Beach, FL 33484-6529 Ph: (561) 495-7570 | Darren Jeremy Bryk, MD 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073-3414 Ph: (954) 943-1133 |
News Archive
In late December 2015, the U.S. Food and Drug Administration proposed a number of new restrictions related to the use of tanning beds, including banning their use among individuals younger than 18 years.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."
Results from a study published in BJU International indicate that penile rehabilitation programs can help restore erectile function following nerve-sparing robot-assisted radical prostatectomy.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Jameson Rybak tried to quit using opioids nearly a dozen times within five years. Each time, he'd wait out the vomiting, sweating and chills from withdrawal in his bedroom.
› Verified 3 days ago
Dr. Marvin L Stein, MD Urology Medicare: Medicare Enrolled Practice Location: 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073 Phone: 954-943-1133 Fax: 954-783-6845 | |
Sanjeev K Gupta, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073 Phone: 954-943-1133 Fax: 954-783-6845 | |
Dr. Kenneth L. Janson, M.D. Urology Medicare: Medicare Enrolled Practice Location: 4443 Lyons Rd Ste 211, Coconut Creek, FL 33073 Phone: 954-405-0501 Fax: 954-301-8501 | |
Dr. Christopher Thomas Tallman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4515 Wiles Rd Ste 201, Coconut Creek, FL 33073 Phone: 954-943-1133 Fax: 954-783-6845 |